Last reviewed · How we verify

NCT04900675: BLISS

Bright Light Intervention to Reduce Students' Stress

Completed NA Last updated 26 June 2025
What this trial tests

NA trial testing Bright light intervention in Psychological Stress in 125 participants. Completed in 31 October 2024.

Timeline
1 October 2020
Primary endpoint
31 March 2024
31 October 2024

Quick facts

Lead sponsorUniversitaet Innsbruck
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment125
Start date1 October 2020
Primary completion31 March 2024
Estimated completion31 October 2024
Sites1 location across Austria

Drugs / interventions tested

Conditions studied

Sponsor

Universitaet Innsbruck

Who can join

Adults 18 to 35, any sex, with Psychological Stress or Physiological Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Increased stress levels are a significant problem for many students and represent a risk factor for impaired mental and physical health as well as academic performance. Stress levels are particularly high during the preparation phase for major exams. There is good evidence that light therapy is an effective treatment option to improve mood in affective disorders. The present study aims at investigating the psychophysiological effects of a 3-week morning bright light exposure in reducing stress and stress-related problems in students preparing for major exams.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Psychological Stress

Currently open trials in the same condition.

Other Universitaet Innsbruck trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04900675.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing